Literature DB >> 16135390

Effects of chemical ischemia in cerebral cortex slices. Focus on nitric oxide.

S Cavallini1, M Marti, S Marino, R Selvatici, L Beani, C Bianchi, A Siniscalchi.   

Abstract

Superfused rat cerebral cortex slices were submitted to a continuous electrical (5 Hz) stimulation and treated with sodium azide (1-10 mM) in the presence of 2 mM 2-deoxyglucose ("chemical ischemia"). Presynaptic cholinergic activity, evaluated as acetylcholine release, was inhibited depending on the sodium azide concentrations and on the length of application (5-30 min). Following a 5-min treatment with 10 mM sodium azide, acetylcholine release was reduced to 45+/-2.3%; simultaneously, there was a 15- and 10-fold increase in glutamate and nitric oxide effluxes, respectively. After restoring normal superfusion conditions, acetylcholine release recovered to 70+/-3.1% of the controls; the N-methyl-D-aspartate receptor antagonist MK-801 (10 microM) as well as the nitric oxide scavengers, haemoglobin (20 microM) and 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-l-oxyl-3-oxide (150 microM), improved the recovery in presynaptic activity, showing that both glutamate and nitric oxide play detrimental roles in chemical ischemia. On the other hand, the post-ischemic recovery was worsened by the guanylylcyclase inhibitor 1H-[l,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one (10 microM), suggesting that the activation of such a pathway plays a neuroprotective role and that the nitric oxide-induced harmful effects depend on different mechanisms. Chemical ischemia-evoked nitric oxide efflux partly derived from its calcium-dependent endogenous synthesis, since both the intracellular calcium chelator, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (1 mM), and the nitric oxide synthase inhibitor, N(omega)-nitro-L-arginine methyl ester (100 microM), substantially prevented sodium azide effects. Nitric oxide efflux was only weakly reduced by MK-801 and was not modified by either the L-type calcium channel blocker, nifedipine (10 microM) or the N-type calcium channel blocker omega-conotoxin (0.5 microM), thus suggesting a prevailing intracellular calcium-dependence of nitric oxide production, although a partial extracellular calcium source cannot be ruled out. These findings show that sodium azide plus 2-deoxyglucose treatment is a useful protocol to induce brain ischemia in vitro and underline the involvement of nitric oxide in the complex events following the ischemic insult.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16135390     DOI: 10.1016/j.neuint.2005.06.003

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  5 in total

1.  Proteomic analysis of primary cultured rat cortical neurons in chemical ischemia.

Authors:  Jung-Woo Seo; Younghoon Kim; Jinyoung Hur; Kang-Sik Park; Young-Wuk Cho
Journal:  Neurochem Res       Date:  2013-05-14       Impact factor: 3.996

2.  Sodium azide induced neuronal damage in vitro: evidence for non-apoptotic cell death.

Authors:  Rita Selvatici; Maurizio Previati; Silvia Marino; Luca Marani; Sofia Falzarano; Irene Lanzoni; Anna Siniscalchi
Journal:  Neurochem Res       Date:  2008-10-08       Impact factor: 3.996

Review 3.  Investigating the mechanisms underlying neuronal death in ischemia using in vitro oxygen-glucose deprivation: potential involvement of protein SUMOylation.

Authors:  Helena Cimarosti; Jeremy M Henley
Journal:  Neuroscientist       Date:  2008-12       Impact factor: 7.519

4.  Antioxidant Potential of Fagonia arabica against the Chemical Ischemia-Induced in PC12 Cells.

Authors:  Ravindra Satpute; Rahul Bhattacharya; Rajpal S Kashyap; Hemant J Purohit; Jayant Y Deopujari; Girdhar M Taori; Hatim F Daginawala
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

5.  Knock-out of a mitochondrial sirtuin protects neurons from degeneration in Caenorhabditis elegans.

Authors:  Rachele Sangaletti; Massimo D'Amico; Jeff Grant; David Della-Morte; Laura Bianchi
Journal:  PLoS Genet       Date:  2017-08-18       Impact factor: 5.917

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.